In this study, we introduce a method to formulate Ginkgolide B lipid microemulsion (GB-LM).
We have assessed its general characteristics and pharmacokinetics in animals. Soybean oil …

The goal of this study was to develop a novel oil-body nanoemulsion (ONE) for Ginkgolide B
(GB) and to conduct pharmacokinetics and pharmacodynamics evaluations. GB-ONE was …

Objective To optimize the formulation of long-circulating solid lipid nanoparticles (LSLN)
carrying ginkgolides A and B (GAB) extracted from traditional Chinese medicinal herbs …

Ginkgolide is the first choice for treatment of cardiovascular and cerebrovascular diseases.
However, its conventional dosage form (ginkgolide injection) can easily produce side effects …

Ligustrazine is a traditional Chinese medicine used to treat various cardiovascular and
neurovascular complications. However, this compound exhibits rapid first-pass metabolism …

The objective of this work was to prepare an oil/water glimepiride (GM) microemulsion (ME)
for oral administration to improve its solubility and enhance its bioavailability. Based on a …

Rationale Ginkgolide B (GB) performs diverse pharmacological activities but has poor water
solubility. The currently available GB injections have a short half‐life and are lethal when …

Background: Ginkgo biloba is therapeutically important fossil species with extended benefits
against CNS disorders as; it contains various potential constituents which are known for their …

To prepare ginkgolide B nanosuspension (GB-NS), and investigate its dissolution behaviors
in vitro. The miniaturized media milling method was used to prepare nanosuspensions, with …

Ginkgolides (GG), containing ginkgolide A (GA), ginkgolide B (GB) and ginkgolide C (GC),
are mainly prescribed for ischemic stroke and cerebral infarction. However, the ginkgolides …